Literature DB >> 16448549

Negative selection of the T-cell repertoire: where and when does it occur?

Harald von Boehmer1, Pawel Kisielow.   

Abstract

Because of the use of somewhat artificial models for the elucidation of negative selection [superantigen, T-cell receptor (TCR) transgenic mice], there is still considerable uncertainty at what stages of T-cell development negative selection can occur and whether it becomes manifest as developmental arrest, lineage diversion, or induction of apoptotic cell death. Here, experimental evidence is reviewed that excludes developmental arrest and lineage diversion as the sole mechanisms of negative selection. The data emphasize that both CD4+ CD8+ double-positive cortical as well as semi-mature, single-positive, medullary thymocytes are targets of deletion in experimental models employing superantigen and TCR transgenic mice with premature as well as 'timely' onset of TCR expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448549     DOI: 10.1111/j.0105-2896.2006.00346.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  23 in total

Review 1.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

2.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 3.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

4.  Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.

Authors:  Ulrike Baranyi; Birgit Linhart; Nina Pilat; Martina Gattringer; Jessamyn Bagley; Ferdinand Muehlbacher; John Iacomini; Rudolf Valenta; Thomas Wekerle
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

5.  Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis.

Authors:  Young I Choi; Jonathan S Duke-Cohan; Wei Chen; Baoyu Liu; Jérémie Rossy; Thibault Tabarin; Lining Ju; Jingang Gui; Katharina Gaus; Cheng Zhu; Ellis L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

6.  E protein transcription factors are required for the development of CD4(+) lineage T cells.

Authors:  Mary Elizabeth Jones-Mason; Xudong Zhao; Dietmar Kappes; Anna Lasorella; Antonio Iavarone; Yuan Zhuang
Journal:  Immunity       Date:  2012-03-15       Impact factor: 31.745

7.  Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.

Authors:  Wong Yu; Ning Jiang; Peter J R Ebert; Brian A Kidd; Sabina Müller; Peder J Lund; Jeremy Juang; Keishi Adachi; Tiffany Tse; Michael E Birnbaum; Evan W Newell; Darrell M Wilson; Gijsbert M Grotenbreg; Salvatore Valitutti; Stephen R Quake; Mark M Davis
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

8.  CD24 on thymic APCs regulates negative selection of myelin antigen-specific T lymphocytes.

Authors:  Xuejun Zhang; Jin-Qing Liu; Yun Shi; Hugh H Reid; Richard L Boyd; Mazin Khattabi; Hani Y El-Omrani; Pan Zheng; Yang Liu; Xue-Feng Bai
Journal:  Eur J Immunol       Date:  2012-01-19       Impact factor: 5.532

9.  B-Raf is required for positive selection and survival of DP cells, but not for negative selection of SP cells.

Authors:  Tara J Dillon; Maho Takahashi; Yanping Li; Srilatha Tavisala; Susan E Murray; Amy E Moran; David C Parker; Philip J S Stork
Journal:  Int Immunol       Date:  2013-01-18       Impact factor: 4.823

10.  A novel TCR transgenic model reveals that negative selection involves an immediate, Bim-dependent pathway and a delayed, Bim-independent pathway.

Authors:  Damian Kovalovsky; Mark Pezzano; Benjamin D Ortiz; Derek B Sant'Angelo
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.